ATE490276T1 - Humanisierte antikörper gegen icam-1, deren herstellung und verwendungen - Google Patents
Humanisierte antikörper gegen icam-1, deren herstellung und verwendungenInfo
- Publication number
- ATE490276T1 ATE490276T1 AT02798403T AT02798403T ATE490276T1 AT E490276 T1 ATE490276 T1 AT E490276T1 AT 02798403 T AT02798403 T AT 02798403T AT 02798403 T AT02798403 T AT 02798403T AT E490276 T1 ATE490276 T1 AT E490276T1
- Authority
- AT
- Austria
- Prior art keywords
- humanized antibodies
- production
- antibodies against
- against icam
- antibodies
- Prior art date
Links
- 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 title abstract 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/910,483 US20030035798A1 (en) | 2000-08-16 | 2001-07-19 | Humanized antibodies |
PCT/US2002/023002 WO2003035696A2 (en) | 2001-07-19 | 2002-07-19 | Humanized antibodies against icam-1, their production and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE490276T1 true ATE490276T1 (de) | 2010-12-15 |
Family
ID=25428849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02798403T ATE490276T1 (de) | 2001-07-19 | 2002-07-19 | Humanisierte antikörper gegen icam-1, deren herstellung und verwendungen |
Country Status (10)
Country | Link |
---|---|
US (4) | US20030035798A1 (de) |
EP (2) | EP2336186A1 (de) |
JP (3) | JP4516312B2 (de) |
AT (1) | ATE490276T1 (de) |
AU (3) | AU2002363027C1 (de) |
CA (2) | CA2454361C (de) |
DE (1) | DE60238485D1 (de) |
DK (1) | DK1414861T3 (de) |
ES (1) | ES2356896T3 (de) |
WO (1) | WO2003035696A2 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1039931T3 (da) * | 1997-12-01 | 2005-08-08 | Fang Fang | Multivalente rekombinante antistoffer til at behandle HRV infektioner |
US20030035798A1 (en) * | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
AU2002365196C1 (en) | 2001-07-19 | 2009-08-13 | Perlan Therapeutics, Inc. | Multimeric proteins and methods of making and using same |
WO2005086568A2 (en) * | 2004-01-26 | 2005-09-22 | Morphosys Ag | Anti-icam-1 human antibodies and uses thereof |
RU2007108716A (ru) * | 2004-09-10 | 2008-10-20 | Вайет (Us) | Гуманизированные антитела к антигену 5т4 и конъюгаты гуманизированного антитела к антигену 5т4 с калихеамицином |
GB2430030B (en) * | 2005-09-07 | 2009-04-01 | Ethicon Inc | Diagnostic markers of wound infection III |
GB0525214D0 (en) | 2005-12-12 | 2006-01-18 | Bioinvent Int Ab | Biological materials and uses thereof |
US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
JP5501439B2 (ja) * | 2009-04-02 | 2014-05-21 | ロシュ グリクアート アクチェンゲゼルシャフト | 完全長抗体と単鎖Fabフラグメントとを含む多重特異的抗体 |
JP5616428B2 (ja) * | 2009-04-07 | 2014-10-29 | ロシュ グリクアート アクチェンゲゼルシャフト | 三価の二重特異性抗体 |
US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
EP2443151A1 (de) | 2009-06-18 | 2012-04-25 | Pfizer Inc. | Anti-notch-1-antikörper |
WO2011034605A2 (en) | 2009-09-16 | 2011-03-24 | Genentech, Inc. | Coiled coil and/or tether containing protein complexes and uses thereof |
TW201138821A (en) | 2010-03-26 | 2011-11-16 | Roche Glycart Ag | Bispecific antibodies |
GB2482536B (en) | 2010-08-05 | 2013-07-24 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
GB2482535A (en) * | 2010-08-05 | 2012-02-08 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
WO2012025530A1 (en) | 2010-08-24 | 2012-03-01 | F. Hoffmann-La Roche Ag | Bispecific antibodies comprising a disulfide stabilized - fv fragment |
WO2012080926A2 (en) * | 2010-12-15 | 2012-06-21 | Wyeth Llc | Anti-notch1 antibodies |
JP5766296B2 (ja) | 2010-12-23 | 2015-08-19 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用 |
MX342034B (es) | 2011-02-28 | 2016-09-12 | Hoffmann La Roche | Proteinas monovalentes que se unen a antigenos. |
RU2607038C2 (ru) | 2011-02-28 | 2017-01-10 | Ф. Хоффманн-Ля Рош Аг | Антигенсвязывающие белки |
MX2014009565A (es) | 2012-02-10 | 2014-11-10 | Genentech Inc | Anticuerpos monocatenarios y otros heteromultimeros. |
WO2014001325A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
ES2597228T3 (es) | 2012-06-27 | 2017-01-17 | F. Hoffmann-La Roche Ag | Procedimiento para la selección y la producción de entidades de objetivación, como dianas, altamente selectivas y multiespecíficas, personalizadas, las cuales contienen por lo menos dos entidades de unión diferentes, y utilización de éstas |
BR112016006929A2 (pt) | 2013-10-11 | 2017-09-19 | Hoffmann La Roche | Anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, métodos de preparação de anticorpo, de tratamento de pacientes e de geração de um anticorpo, composição farmacêutica e uso do anticorpo |
CA2947157A1 (en) * | 2014-05-13 | 2015-11-19 | Chugai Seiyaku Kabushiki Kaisha | T cell-redirected antigen-binding molecule for cells having immunosuppression function |
PL3227332T3 (pl) | 2014-12-03 | 2020-06-15 | F. Hoffmann-La Roche Ag | Wielospecyficzne przeciwciała |
WO2017086367A1 (ja) | 2015-11-18 | 2017-05-26 | 中外製薬株式会社 | 免疫抑制機能を有する細胞に対するt細胞リダイレクト抗原結合分子を用いた併用療法 |
Family Cites Families (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
CH668554A5 (de) | 1984-04-09 | 1989-01-13 | Sandoz Ag | Liposomen welche polypeptide mit interleukin-2-aktivitaet enthalten sowie verfahren zu ihrer herstellung. |
EP0169146A3 (de) | 1984-07-20 | 1988-07-20 | Merck & Co. Inc. | Monoklonale Antikörper gegen den Rezeptor des menschlichen Rhinovirus |
US4698420A (en) * | 1985-02-25 | 1987-10-06 | Xoma Corporation | Antibody hybrid molecules and process for their preparation |
US5077195A (en) * | 1985-03-01 | 1991-12-31 | Board Of Reagents, The University Of Texas System | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
US4975282A (en) | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
DE3682257D1 (de) | 1985-11-22 | 1991-12-05 | Takeda Chemical Industries Ltd | Liposomzusammensetzung. |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5260203A (en) * | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US6121424A (en) * | 1991-11-25 | 2000-09-19 | Enzon, Inc. | Multivalent antigen-binding proteins |
WO1988001649A1 (en) | 1986-09-02 | 1988-03-10 | Genex Corporation | Single polypeptide chain binding molecules |
US5869620A (en) * | 1986-09-02 | 1999-02-09 | Enzon, Inc. | Multivalent antigen-binding proteins |
JP2666345B2 (ja) | 1987-04-16 | 1997-10-22 | 武田薬品工業株式会社 | リポソーム製剤およびその製造法 |
EP0289949B1 (de) | 1987-05-04 | 1995-10-04 | Dana Farber Cancer Institute | Interzellulare Adhäsions-Moleküle und deren Bindungsliganden |
US5565550A (en) | 1987-05-04 | 1996-10-15 | Dana Farber Cancer Institute | Antibodies to ICAM-2, and fragments thereof |
US5284931A (en) | 1987-05-04 | 1994-02-08 | Dana Farber Cancer Institute | Intercellular adhesion molecules, and their binding ligands |
US5273876A (en) | 1987-06-26 | 1993-12-28 | Syntro Corporation | Recombinant human cytomegalovirus containing foreign gene |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
EP0364096B1 (de) | 1988-09-06 | 2000-03-08 | Xoma Corporation | Genexpressions-Elemente und Herstellung von chimären Maus-Mensch-Antikörpern |
ATE125708T1 (de) | 1988-09-28 | 1995-08-15 | Dana Farber Cancer Inst Inc | Interzellulare adhäsions-moleküle und deren bindungsliganden. |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
WO1990009441A1 (en) | 1989-02-01 | 1990-08-23 | The General Hospital Corporation | Herpes simplex virus type i expression vector |
US5665577A (en) | 1989-02-06 | 1997-09-09 | Dana-Farber Cancer Institute | Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof |
DK0387701T3 (da) | 1989-03-09 | 1992-12-07 | Boehringer Ingelheim Pharma | Anvendelse af intercellulære adhæsionsmolekyler samt deres bindende ligander ved behandling af astma |
US5081584A (en) * | 1989-03-13 | 1992-01-14 | United States Of America | Computer-assisted design of anti-peptides based on the amino acid sequence of a target peptide |
AU627591B2 (en) | 1989-06-19 | 1992-08-27 | Xoma Corporation | Chimeric mouse-human km10 antibody with specificity to a human tumor cell antigen |
US5324510A (en) | 1989-09-01 | 1994-06-28 | Boehringer Ingelheim Pharmaceuticals, Inc. | Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma |
EP0453554A4 (en) | 1989-11-13 | 1993-02-17 | Xoma Corporation | Chimeric mouse human antibodies with specificity to hiv antigens |
AU634314B2 (en) | 1989-11-13 | 1993-02-18 | Green Cross Corporation, The | Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
KR920701441A (ko) | 1989-11-13 | 1992-08-11 | 원본미기재 | Hiv 항원에 특이성을 가지는 키메릭 마우스 인간 항체 |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
GB9009549D0 (en) * | 1990-04-27 | 1990-06-20 | Celltech Ltd | Recombinant antibody and method |
GB9009548D0 (en) | 1990-04-27 | 1990-06-20 | Celltech Ltd | Chimeric antibody and method |
EP0459577A3 (en) | 1990-06-01 | 1992-08-05 | Merck & Co. Inc. | Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors |
US5723286A (en) | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
JPH06500923A (ja) | 1990-09-21 | 1994-01-27 | カイロン コーポレイション | パッケージング細胞 |
US5582996A (en) * | 1990-12-04 | 1996-12-10 | The Wistar Institute Of Anatomy & Biology | Bifunctional antibodies and method of preparing same |
CA2104396C (en) | 1991-02-19 | 2000-10-10 | Jiing-Kuan Yee | Viral particles having altered host range |
GB9105383D0 (en) | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
US5223396A (en) | 1991-05-03 | 1993-06-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for detecting organ transplant rejection |
JP4124480B2 (ja) | 1991-06-14 | 2008-07-23 | ジェネンテック・インコーポレーテッド | 免疫グロブリン変異体 |
ATE181571T1 (de) | 1991-09-23 | 1999-07-15 | Medical Res Council | Methoden zur herstellung humanisierter antikörper |
ES2136092T3 (es) * | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
US5716805A (en) * | 1991-10-25 | 1998-02-10 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
EP0617706B1 (de) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalente antigen-bindende proteine |
US5932448A (en) | 1991-11-29 | 1999-08-03 | Protein Design Labs., Inc. | Bispecific antibody heterodimers |
US5766886A (en) | 1991-12-13 | 1998-06-16 | Xoma Corporation | Modified antibody variable domains |
CA2128511C (en) | 1992-01-23 | 2006-11-07 | Andreas Pluckthun | Monomeric and dimeric antibody-fragment fusion proteins |
US6129914A (en) | 1992-03-27 | 2000-10-10 | Protein Design Labs, Inc. | Bispecific antibody effective to treat B-cell lymphoma and cell line |
AU3972893A (en) | 1992-04-03 | 1993-11-08 | Baylor College Of Medicine | Gene therapy using the intestine |
US6329507B1 (en) * | 1992-08-21 | 2001-12-11 | The Dow Chemical Company | Dimer and multimer forms of single chain polypeptides |
US5639641A (en) * | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
US5832448A (en) * | 1996-10-16 | 1998-11-03 | Health Hero Network | Multiple patient monitoring system for proactive health management |
AU5670194A (en) * | 1992-11-20 | 1994-06-22 | Enzon, Inc. | Linker for linked fusion polypeptides |
US5674703A (en) | 1992-12-02 | 1997-10-07 | Woo; Savio L. C. | Episomal vector systems and related methods |
US5837242A (en) * | 1992-12-04 | 1998-11-17 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
US6307026B1 (en) * | 1992-12-10 | 2001-10-23 | Celltech Limited | Humanized antibodies directed against A33 antigen |
FR2702160B1 (fr) | 1993-03-02 | 1995-06-02 | Biovecteurs As | Vecteurs particulaires synthétiques et procédé de préparation. |
US5491074A (en) * | 1993-04-01 | 1996-02-13 | Affymax Technologies Nv | Association peptides |
US5662899A (en) * | 1993-05-18 | 1997-09-02 | I.D.M. Immuno-Designed Molecules | Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
EP0728202A4 (de) | 1993-11-12 | 1997-04-23 | Univ Case Western Reserve | Episomales expressionsvektor für die menschliche gentherapy |
US5928944A (en) | 1994-02-04 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method of adenoviral-medicated cell transfection |
US5731172A (en) | 1994-03-09 | 1998-03-24 | Sumitomo Pharmaceuticals Company, Ltd. | Recombinant adenovirus and process for producing the same |
GB9409768D0 (en) * | 1994-05-16 | 1994-07-06 | Medical Res Council | Trimerising polypeptides |
US5604090A (en) | 1994-06-06 | 1997-02-18 | Fred Hutchinson Cancer Research Center | Method for increasing transduction of cells by adeno-associated virus vectors |
US5763733A (en) * | 1994-10-13 | 1998-06-09 | Enzon, Inc. | Antigen-binding fusion proteins |
US5693508A (en) | 1994-11-08 | 1997-12-02 | Chang; Lung-Ji | Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats |
US5573925A (en) * | 1994-11-28 | 1996-11-12 | The Wistar Institute Of Anatomy And Biology | P53 proteins with altered tetramerization domains |
US5721340A (en) * | 1994-11-28 | 1998-02-24 | The Wistar Institute Of Anatomy & Biology | p53 proteins with altered tetramerization domains |
US5632448A (en) * | 1995-01-25 | 1997-05-27 | Ransburg Corporation | Rotary powder applicator |
US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
JP3770333B2 (ja) | 1995-03-15 | 2006-04-26 | 大日本住友製薬株式会社 | 組換えdnaウイルスおよびその製造方法 |
EP0827544B1 (de) * | 1995-05-23 | 2004-08-18 | MorphoSys AG | Multimere proteine |
US6110456A (en) | 1995-06-07 | 2000-08-29 | Yale University | Oral delivery or adeno-associated viral vectors |
JP2783276B2 (ja) * | 1995-07-04 | 1998-08-06 | 日本電気株式会社 | 半導体装置の製造方法 |
WO1997005249A2 (en) | 1995-07-31 | 1997-02-13 | The Government Of The United States Of America, Represented By The Secretary, Department Of Healt H And Human Services | Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
JP2000504934A (ja) | 1995-12-22 | 2000-04-25 | バクスター バイオテク テクノロジー エス.アー.アール.エル. | 結合ドメインを含むグロビン |
ATE318147T1 (de) * | 1996-03-25 | 2006-03-15 | Medarex Inc | Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen |
US5861397A (en) | 1996-10-03 | 1999-01-19 | Vical Incorporated | Piperazine based cytofectins |
US6096291A (en) | 1996-12-27 | 2000-08-01 | Biovector Therapeutics, S.A. | Mucosal administration of substances to mammals |
DE69841815D1 (de) * | 1997-04-07 | 2010-09-16 | Genentech Inc | Anti-VEGF Antikörper |
DK1039931T3 (da) | 1997-12-01 | 2005-08-08 | Fang Fang | Multivalente rekombinante antistoffer til at behandle HRV infektioner |
JPH11228446A (ja) * | 1998-02-16 | 1999-08-24 | Mitsubishi Chemical Corp | 抗マラリア剤 |
US20020165153A1 (en) | 1998-04-06 | 2002-11-07 | Peter Angel | Transcription factors and their use |
US5965712A (en) * | 1998-06-19 | 1999-10-12 | Virginia Commonwealth University | LZ-CD23 chimera for inhibition of IgE-mediated allergic disease |
SK287491B6 (sk) * | 1998-10-16 | 2010-11-08 | Biogen Idec Ma Inc. | Fúzne proteíny interferónu- beta-1a a ich použitie |
US20030035798A1 (en) | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
MXPA01005515A (es) | 1998-12-01 | 2003-07-14 | Protein Design Labs Inc | Anticuerpos humanizados para gamma-interferon. |
CA2377513A1 (en) | 1999-06-25 | 2001-01-04 | Universitat Zurich | Hetero-associating coiled-coil peptides |
RU2002110116A (ru) | 1999-09-17 | 2004-03-10 | Джитиси Байотерапьютикс, Инк. (Us) | Гибридные белки, оптимизированные по субъединицам |
AUPQ425699A0 (en) * | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
CA2382165A1 (en) * | 1999-12-08 | 2001-06-14 | Genset S.A. | Full-length human cdnas encoding potentially secreted proteins |
ATE442386T1 (de) | 2000-04-28 | 2009-09-15 | Planet Biotechnology Inc | Immunoadhesin zur impfung gegen rhinovirus |
AU2002365196C1 (en) | 2001-07-19 | 2009-08-13 | Perlan Therapeutics, Inc. | Multimeric proteins and methods of making and using same |
JP4236000B2 (ja) | 2003-09-25 | 2009-03-11 | 元気株式会社 | 3次元画像処理装置、3次元画像処理方法及びプログラム |
-
2001
- 2001-07-19 US US09/910,483 patent/US20030035798A1/en not_active Abandoned
-
2002
- 2002-07-19 WO PCT/US2002/023002 patent/WO2003035696A2/en active Application Filing
- 2002-07-19 EP EP10010857A patent/EP2336186A1/de not_active Withdrawn
- 2002-07-19 EP EP02798403A patent/EP1414861B1/de not_active Expired - Lifetime
- 2002-07-19 DK DK02798403.8T patent/DK1414861T3/da active
- 2002-07-19 JP JP2003538209A patent/JP4516312B2/ja not_active Expired - Fee Related
- 2002-07-19 ES ES02798403T patent/ES2356896T3/es not_active Expired - Lifetime
- 2002-07-19 AU AU2002363027A patent/AU2002363027C1/en not_active Ceased
- 2002-07-19 CA CA2454361A patent/CA2454361C/en not_active Expired - Fee Related
- 2002-07-19 AT AT02798403T patent/ATE490276T1/de not_active IP Right Cessation
- 2002-07-19 CA CA2793019A patent/CA2793019A1/en not_active Abandoned
- 2002-07-19 DE DE60238485T patent/DE60238485D1/de not_active Expired - Lifetime
-
2006
- 2006-09-11 US US11/519,322 patent/US7696324B2/en not_active Expired - Fee Related
-
2008
- 2008-12-18 AU AU2008258214A patent/AU2008258214B2/en not_active Ceased
-
2009
- 2009-05-15 JP JP2009119326A patent/JP2009183303A/ja active Pending
-
2010
- 2010-03-26 US US12/748,304 patent/US8586712B2/en not_active Expired - Fee Related
-
2012
- 2012-06-07 AU AU2012203365A patent/AU2012203365A1/en not_active Abandoned
-
2013
- 2013-02-14 JP JP2013026399A patent/JP2013116119A/ja active Pending
- 2013-11-18 US US14/083,146 patent/US20140308269A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005524385A (ja) | 2005-08-18 |
AU2012203365A1 (en) | 2012-06-28 |
CA2454361A1 (en) | 2003-05-01 |
CA2454361C (en) | 2013-01-08 |
ES2356896T3 (es) | 2011-04-14 |
AU2008258214A1 (en) | 2009-01-15 |
DE60238485D1 (de) | 2011-01-13 |
DK1414861T3 (da) | 2011-03-21 |
WO2003035696A3 (en) | 2003-11-27 |
CA2793019A1 (en) | 2003-05-01 |
JP2009183303A (ja) | 2009-08-20 |
US20070071742A1 (en) | 2007-03-29 |
JP4516312B2 (ja) | 2010-08-04 |
EP2336186A1 (de) | 2011-06-22 |
US20140308269A1 (en) | 2014-10-16 |
AU2002363027B2 (en) | 2008-09-18 |
AU2002363027C1 (en) | 2009-04-30 |
US8586712B2 (en) | 2013-11-19 |
US20110044976A1 (en) | 2011-02-24 |
WO2003035696A2 (en) | 2003-05-01 |
US20030035798A1 (en) | 2003-02-20 |
US7696324B2 (en) | 2010-04-13 |
JP2013116119A (ja) | 2013-06-13 |
AU2008258214B2 (en) | 2012-03-08 |
EP1414861B1 (de) | 2010-12-01 |
EP1414861A2 (de) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE490276T1 (de) | Humanisierte antikörper gegen icam-1, deren herstellung und verwendungen | |
DE50303413D1 (de) | Befestigungsmittel und Verfahren zu seiner Herstellung | |
DE60126099D1 (de) | Kristallines und reines modafinil und verfahren zu seiner herstellung | |
ATE309196T1 (de) | Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte | |
DE122012000001I1 (de) | Humane antikorper gegen CTLA-4 und deren verwendungen. | |
DE69535133D1 (de) | Humanisierte antikörper gegen das leukozytenadhäsionsmolekül vla-4 | |
ATE481108T1 (de) | Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen | |
DE50214717D1 (de) | Und verfahren zu seiner herstellung | |
DE50212077D1 (de) | Piezoelektrisches bauelement und verfahren zu dessen herstellung | |
ATE507224T1 (de) | Verfahren und zwischenverbindungen zur herstellung von n4-phenyl-quinazolin-4-amin derivaten | |
DE60317586D1 (de) | Verfahren zur Herstellung von mehrschichtigen, halbleitenden Nanopartikeln und und die nach diesem Verfahren erhaltenen mehrschichtigen, halbleitenden Nanopartikel | |
DE60110044D1 (de) | Teilentwässertes umsetzungsprodukt, verfahren zur herstellung desselben, und dasselbe enthaltende emulsion | |
ATE304062T1 (de) | Vollnarbiges rindnappaleder und verfahren zur herstellung desselben | |
DE60231885D1 (de) | Flammhemmende polyesterzusammensetzung, verfahren zu deren herstellung, und daraus hergestellte artikel | |
DE60201390D1 (de) | Kondensatormikrofon und Verfahren zur dessen Herstellung | |
ATE388135T1 (de) | Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen | |
DE60111904D1 (de) | Biosensor und verfahren zu dessen herstellung | |
DE60333304D1 (de) | Gleitteil und verfahren zur herstellung des gleitteils | |
DE60227517D1 (de) | Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid | |
ATE199321T1 (de) | Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen. | |
ATE362490T1 (de) | Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung | |
ATA5752001A (de) | Kabelführung und verfahren zum herstellen derselben | |
ATE339437T1 (de) | 5-androsten-3-olsteroidzwischenprodukte und verfahren zu deren herstellung | |
DE60116581D1 (de) | Verfahren zur Fluorierung von 1,1,1,3,3-Pentachloropropan | |
DE60201440D1 (de) | Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |